ASPCF News and Press, Acerus Pharmaceuticals Corp From 10/27/20

Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its third quarter 2020 financial and operating results on Tuesday, November 3, 2020 before the market opens. The company will host a conference call on Tuesday, November 3, 2020 at 10:00 a.m. Eastern Time. To ac...

Acerus Pharmaceuticals (ASPCF) reports offering rights to its shares holders at the close of business on October 27.Record date stockholders will receive one transferable right for each share held; for every 1.91984064 rights held, a rights holder may buy one new shar...

Acerus Pharmaceuticals Corporation (“ Acerus ” or the “ Company ”) (TSX: ASP, OTCQB: ASPCF) is pleased to announce that it will be offering rights (the " Rights Offering ") to holders of its common shares (" Common Shares ") of record at t...

Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP, OTCQB: ASPCF) today announced that the Company has received a waiver letter from SWK Funding LLC (“SWK”) related to the required Revenue Covenant for the third quarter of ...

Kevin Hickey Joins Acerus’ Executive Leadership Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP, OTCQB: ASPCF) today announced that Kevin Hickey has joined the Company as Senior Vice President, US Commercial. Mr. Hickey will b...

Acerus Pharmaceuticals Corporation (ASPCF) Q2 2020 Earnings Conference Call August 11, 2020, 10:00 AM ET Company Participants Bob Motz - CFO Ed Gudaitis - President and CEO Conference Call Participants Presentation Operator Good morning, ladies and gentlemen, and welc...

Acerus Pharmaceuticals ( OTCQB:ASPCF ) : Q2 GAAP EPS of -$0.01. More news on: Acerus Pharmaceuticals Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...

Moving Forward During Pandemic; Setting Stage for Growth in 2020 and Beyond Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP; OTCQB:ASPCF) today reported its financial results for the three and six-month period ended June 30, 2020. Unl...

Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) (“Acerus” or the “Company”) today announced that it will issue second quarter 2020 financial and operating results on Tuesday August 11, 2020 before the market opens. The Company will host an investor confer...

Product En Route to United States and Taiwan Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF), a speciality pharmaceutical company focused on the commercialization of novel prescription products for men’s health, today announced that production of new batches of NATESTO...